Peptinovo Biopharma
About this raise
Peptinovo Biopharma, with a valuation of $19 million, is raising funds on Silicon Prairie Online. The company has developed a smart drug-delivery platform designed to specifically target cancer cells. Peptinovo Biopharma’s PALM platform aims to improve the effectiveness of chemotherapy drugs and minimize their harmful effects on patients. PALM exploits specific nutrient pathways and tricks the cancer cells to deliver approved chemotherapy drugs directly into the cancer cells. Ren Homan and Bill Elliott founded Peptinovo Biopharma in April 2020. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1.25 million. The campaign proceeds will be used for the growth and development of the platform.
Investment Overview
Committed : $30,000
Deal Terms
Total Commitments
- Platform
- Silicon Prairie Online
- Start Date
- 03/12/2025
- Close Date
- 09/04/2025
$50,000
$1,250,000
$2,500
Equity - Preferred
Series A
RegCF
$3.39
$19,000,000
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- Medium
- Capital Intensity
- High
Financials
- Revenue -21.6% YoY
- $1,545
- Monthly Burn
- $60,000
-
Runway
- 5.8 months
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $8,500,000
- Grants
- $45,900
- VC Backed?
- Yes
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 09/04/2025 | Silicon Prairie Online | $19,000,000 | $30,000 | Equity - Preferred | Active | RegCF |